Bentham Science Logo

Letters in Drug Design & Discovery

Volume 16, 12 Issues, 2019
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access

Ranking and Category

  • 57th of 61 in

    Chemistry, Medicinal

Order Your Article Before Print

Contents

Letters in Drug Design & Discovery, Volume 2 - Number 1





Farnesyltransferase Inhibitors: Overview of their Action and Role in Solid Malignancy Therapy

, 2(1): 26 - 35

Stefano Margaritora, Alfredo Cesario, Venanzio Porziella, Pierluigi Granone, Alessia Catassi and Patrizia Russo


DOI: 10.2174/1570180053398361



Design of a Heteroaryl Modified, 1,5-Disubstituted Pyrazole Cyclooxygenase-2 (COX-2) Selective Inhibitor

, 2(1): 40 - 43

M. Ezawa, D. S. Garvey, D. R. Janero, S. P. Khanapure, L. G. Letts, A. Martino, R. R. Ranatunge, D. J. Schwalb and D. V. Young


DOI: 10.2174/1570180053398451













Editor-in-Chief

K. Kuca
University of Hradec Kralove
Hradec Kralove
Czech Republic

Biography View Full Editorial Board

Journal History

Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog